Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
about
Prostate cancer: ESMO Consensus Conference Guidelines 2012Long-term functional outcomes after treatment for localized prostate cancer.Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trialCost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.Are there specific health-related factors that can accentuate the risk of suicide among men with prostate cancer?The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer.Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis.Exploring the feasibility and acceptability of couple-based psychosexual support following prostate cancer surgery: study protocol for a pilot randomised controlled trialProstate volume and biopsy tumor length are significant predictors for classical and redefined insignificant cancer on prostatectomy specimens in Japanese men with favorable pathologic features on biopsyProstate cancer outcomes in France: treatments, adverse effects and two-year mortalityPatient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer.Radical prostatectomy or watchful waiting in early prostate cancer.Quality-of-life effects of prostate-specific antigen screening.Recommendations on screening for prostate cancer with the prostate-specific antigen test.Phospho-Akt immunoreactivity in prostate cancer: relationship to disease severity and outcome, Ki67 and phosphorylated EGFR expressionSexual dysfunction and infertility as late effects of cancer treatment.Effects of surgeon variability on oncologic and functional outcomes in a population-based settingDefining young in the context of prostate cancer.Establishing a population-based patient-reported outcomes study (PROMs) using national cancer registries across two jurisdictions: the Prostate Cancer Treatment, your experience (PiCTure) study.Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy.Treatment of localized prostate cancer in elderly patients.Physical activity, sedentary behavior, and health-related quality of life in prostate cancer survivors in the health professionals follow-up study.Symptomatic and quality-of-life outcomes after treatment for clinically localised prostate cancer: a systematic review.Physical activity before radical prostatectomy reduces sick leave after surgery - results from a prospective, non-randomized controlled clinical trial (LAPPRO).Active surveillance for low-risk prostate cancer.A Longitudinal Study of Predictors of Sexual Dysfunction in Men on Active Surveillance for Prostate CancerUnexpected Long-term Improvements in Urinary and Erectile Function in a Large Cohort of Men with Self-reported Outcomes Following Radical Prostatectomy.Radical prostatectomy versus observation for localized prostate cancer.Distress, delay of gratification and preference for palliative care in men with prostate cancer.Population-based study of long-term functional outcomes after prostate cancer treatment.Temporal trends in cause of death among Swedish and US men with prostate cancer.Results from the Scandinavian Prostate Cancer Group Trial Number 4: a randomized controlled trial of radical prostatectomy versus watchful waiting.Quality of life in men undergoing active surveillance for localized prostate cancer.Medical Help-Seeking for Sexual Concerns in Prostate Cancer Survivors.Five-year downstream outcomes following prostate-specific antigen screening in older menDivorcing diagnosis from treatment: contemporary management of low-risk prostate cancer.Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatmentDetection rate of clinically insignificant prostate cancer increases with repeat prostate biopsiesControversies on individualized prostate cancer care: gaps in current practice.Long-term cancer-related fatigue outcomes in patients with locally advanced prostate cancer after intensity-modulated radiotherapy combined with hormonal therapy.
P2860
Q27022847-FBCD0302-BD70-42A8-B20E-4C4686545125Q30542816-AFAFF243-4A47-46AE-9C4D-7DB0C6A71C7EQ30845863-048C8E9E-0A88-43E6-8326-F75375714E35Q30878080-3D933555-6842-4419-9258-A8B2F6400636Q33561281-9E866333-93A2-4069-82BB-F8BDBB9233E7Q33617669-B6BC4AF5-12AA-4292-ADBC-B5ABF63E73E0Q33626084-DBB9786D-8163-40B7-924A-C12E5A263FABQ33689376-038EA50B-717D-471A-8854-EC123247D4F1Q33717988-F78C08B7-CF18-47BF-BEF4-5FC4B7520528Q33795089-6D5072AE-76CF-49C7-859D-A3232060F1F4Q33851417-96436C39-09C1-42AE-9FC3-C71E0AFF866EQ33985455-E0EB8214-208C-468A-A97D-257EBA601F42Q34294102-20B3A5E5-7335-4621-A774-67C1FFD9977CQ34435885-4790EC9A-2C73-4AC8-9BF3-95E56A062A4DQ34469245-7C96A3EB-C33E-4DEB-A67A-56EE55A1AB1CQ34604454-D14F99FB-E8DC-45EA-927A-F6406688C40AQ35112495-3EFBAE67-46E7-485D-8D07-F8EB5C5A24EBQ35181814-D7D4DE93-40A2-499D-8236-8739B68DF49CQ35466577-BB85992F-F8F2-4A67-B420-75F88656B716Q35812145-8BE4F029-76E1-4D62-9DAC-0F6FDA1810F1Q35912658-D042C92F-EBD0-4EE3-A87F-02FD86F97A97Q35958199-94627262-F8D6-4607-B146-1AD4661FDE0DQ35992097-D8E6EE3E-89A9-4A84-AFAD-FD35734F2E79Q36105314-1022874E-2D43-42E3-B7B6-E03FD2ECD34CQ36141777-FBA4F99B-A073-45E0-AF6B-FB9BC2D81AD6Q36142085-D3727E30-83F8-4A08-8C57-A4E874B20175Q36161863-E278054C-9966-4200-A741-5ADE1D13A6A7Q36194308-ED610B9C-D995-44A5-8DFD-6409D14667BCQ36200494-0F375056-5DBB-4C8C-842C-392788B6DF97Q36260481-E549C7E3-8E94-4813-BD04-94C3127CAC4EQ36486777-AACFDECE-3182-43DA-85E7-5E3E51D4E060Q36520496-F61B0E02-EA3D-4368-A218-033DAC60A649Q36520543-85C21358-1E31-4658-8E41-70BBF055CBAAQ36770061-5FCC1A0C-544C-4786-BEA7-10B312EC5B9DQ37017183-F7C7844D-9971-455F-8873-858E7A4CC38EQ37025434-CAC3DFC1-03DF-4953-9718-1AEDC14D5FC0Q37059743-EFF592B1-1C5B-4437-A130-0B9A7DB89C1FQ37084223-B86A900D-6031-42BF-87B3-B30083BB1C6DQ37149085-A93C2044-A9CB-40A9-AFDE-80789A9400DAQ37205167-F04A904D-FBCF-4ADE-88DD-3A332273EADC
P2860
Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Long-term quality-of-life outc ...... ncer Group-4 randomised trial.
@en
Long-term quality-of-life outc ...... ncer Group-4 randomised trial.
@nl
type
label
Long-term quality-of-life outc ...... ncer Group-4 randomised trial.
@en
Long-term quality-of-life outc ...... ncer Group-4 randomised trial.
@nl
prefLabel
Long-term quality-of-life outc ...... ncer Group-4 randomised trial.
@en
Long-term quality-of-life outc ...... ncer Group-4 randomised trial.
@nl
P2093
P50
P1433
P1476
Long-term quality-of-life outc ...... ncer Group-4 randomised trial.
@en
P2093
Anna Bill-Axelson
Eva Johansson
Jan-Erik Johansson
Mirja Ruutu
SPCG-4 Investigators
P304
P356
10.1016/S1470-2045(11)70162-0
P577
2011-08-05T00:00:00Z